Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro(TM) ER for Management of Chronic Pain

Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro(TM) ER for Management of Chronic Pain

[at noodls] – Zogenix to Host Conference Call on Dec. 7, 2012 at 6:30 p.m. ET SAN DIEGO, Dec. 7, 2012 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products … more

View todays social media effects on ZGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Zogenix is hiring next, click here to view

Share this post

Comments (0)